India's Suven Pharma hits over 2-month low on Q3 profit slump
** Shares of Suven Pharmaceuticals SUVH.NS fall as much as
10.4% to 585.2 rupees, lowest level since Nov. 20
** The pharma co said on Monday its Q3 net profit more than
halved to 523.6 mln rupees ($6.3 mln), rev from ops slipped ~39%
Y/Y
** More than 665,000 shares change hands, 3.5x its 30-day
avg
** Stock fell ~7% in January, snapping eight consecutive
monthly gains
($1 = 83.0380 Indian rupees)
(Reporting by Ashna Teresa Britto in Bengaluru)
((AshnaTeresa.Britto@thomsonreuters.com ; ( +91 8078332441))
Recent news on Cohance Lifesciences
See all newsBrief: Cohance Lifesciences Names Abhimanyu Ojha As CFO
Brief: Cohance Lifesciences Says U.S. FDA Issues Form 483 With Five Observations For Jaggaiahpet Unit In Andhra Pradesh
India's Cohance Lifesciences falls after US FDA inspection at Telangana plant
Brief: Cohance Lifesciences Says Investment Of USD 18 Million In NJ Bio And Aruka Bio
India's Cohance Lifesciences climbs on second-half growth outlook despite Q1 loss